Cowen and Company’s Globus Medical GMED Stock Holding History

Cowen and Company’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-2,420	Closed	-$103K	–	426
2020 Q1	$103K	Buy	+2,420	New	+$120K	0.02%	245

Other funds holding GMED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VBA

Van Berkom & Associates Montreal, Quebec, Canada $3.08B AUM 12.07% 1-Year Est. Return

Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Cowen and Company's GMED Position: Q2 2020 in Review

Cowen and Company sold out of Globus Medical (GMED) in Q2 2020, closing a stake of 2,420 shares — an estimated $103K sold.

Cowen and Company first reported a position in GMED in Q1 2020 and held it in 1 quarter. The position peaked at $103K in Q1 2020. 322 funds tracked by Wall St. Rank hold GMED as of Q2 2020.

Cowen and Company reported no remaining Globus Medical position as of Q2 2020 after selling out during the quarter.
Cowen and Company sold 2,420 Globus Medical shares in Q2 2020, an estimated $103K.
Cowen and Company first reported a position in Globus Medical in Q1 2020 and held it in 1 quarter.
Cowen and Company's Globus Medical position peaked at $103K in Q1 2020.
322 funds tracked by Wall St. Rank held Globus Medical as of Q2 2020.

Based on Cowen and Company's 13F filing for Q2 2020, filed 13 Aug 2020.